James S. Rush

2.2k total citations
26 papers, 1.3k citations indexed

About

James S. Rush is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James S. Rush has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James S. Rush's work include T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (6 papers). James S. Rush is often cited by papers focused on T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (6 papers). James S. Rush collaborates with scholars based in United States, Switzerland and Germany. James S. Rush's co-authors include John Chalmers, Daniel H.D. Gray, Philip D. Hodgkin, Gianluca Carlesso, Natalie M. Edner, Lucy S. K. Walker, Charles J. Waechter, David G. Schatz, Valerie Odegard and Shyam Unniraman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

James S. Rush

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James S. Rush United States 17 581 377 248 243 167 26 1.3k
Shuji Sumitomo Japan 23 804 1.4× 392 1.0× 140 0.6× 399 1.6× 339 2.0× 70 1.7k
Yoshinori Katada Japan 17 462 0.8× 391 1.0× 117 0.5× 529 2.2× 333 2.0× 46 1.4k
Kayoko Sato Japan 17 650 1.1× 275 0.7× 169 0.7× 114 0.5× 163 1.0× 52 1.1k
Sabine Stegmaier Germany 21 466 0.8× 494 1.3× 150 0.6× 133 0.5× 267 1.6× 37 1.5k
Katsuaki Kanbe Japan 23 410 0.7× 271 0.7× 295 1.2× 705 2.9× 312 1.9× 66 1.7k
Manabu Inobe Japan 23 497 0.9× 467 1.2× 121 0.5× 287 1.2× 196 1.2× 49 1.2k
Paolo Durigutto Italy 21 715 1.2× 248 0.7× 185 0.7× 658 2.7× 139 0.8× 31 1.6k
Jean‐Claude Bensa France 18 579 1.0× 198 0.5× 133 0.5× 254 1.0× 223 1.3× 48 1.2k
Tamara H. Ramwadhdoebé Netherlands 21 1.0k 1.7× 293 0.8× 211 0.9× 379 1.6× 522 3.1× 29 1.7k
Yuki Nanke Japan 20 506 0.9× 511 1.4× 86 0.3× 610 2.5× 279 1.7× 83 1.5k

Countries citing papers authored by James S. Rush

Since Specialization
Citations

This map shows the geographic impact of James S. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Rush more than expected).

Fields of papers citing papers by James S. Rush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Rush. The network helps show where James S. Rush may publish in the future.

Co-authorship network of co-authors of James S. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Rush. A scholar is included among the top collaborators of James S. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Rush. James S. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wittner, Jens, Christian H.K. Lehmann, Mandy Wahlbuhl, et al.. (2025). CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells. Clinical & Experimental Immunology. 219(1).
2.
Shi, Tiffany, Ashley R. Burg, J. Timothy Caldwell, et al.. (2023). Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality. Journal of Clinical Investigation. 133(14). 22 indexed citations
3.
Willemsen, Joschka, Thomas Hoyler, Sophie Sarret, et al.. (2021). TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis. Cell Reports. 37(6). 109977–109977. 144 indexed citations
4.
Edner, Natalie M., Gianluca Carlesso, James S. Rush, & Lucy S. K. Walker. (2020). Targeting co-stimulatory molecules in autoimmune disease. Nature Reviews Drug Discovery. 19(12). 860–883. 146 indexed citations
5.
Edner, Natalie M., Gianluca Carlesso, James S. Rush, & Lucy S. K. Walker. (2020). Publisher Correction: Targeting co-stimulatory molecules in autoimmune disease. Nature Reviews Drug Discovery. 20(1). 82–82. 3 indexed citations
6.
Wieczorek, Grazyna, et al.. (2019). Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Annals of the Rheumatic Diseases. 78(7). 974–978. 31 indexed citations
7.
Kahaly, George J., Marius N. Stan, Lara Frommer, et al.. (2019). A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves’ Hyperthyroidism – A Proof-Of-Concept Trial. The Journal of Clinical Endocrinology & Metabolism. 2 indexed citations
8.
Espié, Pascal, Yanling He, Phillip J. Koo, et al.. (2019). First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American Journal of Transplantation. 20(2). 463–473. 68 indexed citations
9.
Kahaly, George J., Marius N. Stan, Lara Frommer, et al.. (2019). A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial. The Journal of Clinical Endocrinology & Metabolism. 105(3). 696–704. 69 indexed citations
10.
Espié, Pascal, Peter Ulrich, Denise Sickert, et al.. (2018). Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody. American Journal of Transplantation. 18(12). 2895–2904. 74 indexed citations
11.
Aprea, Susanna, Tom Wu, M. Cooke, et al.. (2015). A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells. Human Vaccines & Immunotherapeutics. 11(8). 2038–2050. 23 indexed citations
12.
13.
Rush, James S., Sergey V. Matveev, Ziqiang Guan, Christian R.H. Raetz, & Charles J. Waechter. (2010). Expression of functional bacterial undecaprenyl pyrophosphate synthase in the yeast rer2  mutant and CHO cells. Glycobiology. 20(12). 1585–1593. 10 indexed citations
14.
Rush, James S., Man Liu, Valerie Odegard, Shyam Unniraman, & David G. Schatz. (2005). Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination. Proceedings of the National Academy of Sciences. 102(37). 13242–13247. 78 indexed citations
15.
Rush, James S.. (2004). Staggered AID-dependent DNA double strand breaks are the predominant DNA lesions targeted to S  in Ig class switch recombination. International Immunology. 16(4). 549–557. 85 indexed citations
16.
Fugmann, Sebastian D., James S. Rush, & David G. Schatz. (2004). Non‐redundancy of cytidine deaminases in class switch recombination. European Journal of Immunology. 34(3). 844–849. 17 indexed citations
17.
Rush, James S., Jhagvaral Hasbold, & Philip D. Hodgkin. (2002). Cross-Linking Surface Ig Delays CD40 Ligand- and IL-4-Induced B Cell Ig Class Switching and Reveals Evidence for Independent Regulation of B Cell Proliferation and Differentiation. The Journal of Immunology. 168(6). 2676–2682. 31 indexed citations
18.
Rush, James S., Panneerselvam Krishnamurthy, Charles J. Waechter, & Hudson H. Freeze. (2000). Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with Congenital Disorders of Glycosylation (CDG). Glycobiology. 10(8). 829–835. 47 indexed citations
19.
20.
Hodgkin, Philip D., et al.. (1998). The logic of intercellular communication in the immune system. Immunology and Cell Biology. 76(5). 448–453. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuji Sumitomo Breakdown of academic impact, for papers by Yoshinori Katada Breakdown of academic impact, for papers by Kayoko Sato Breakdown of academic impact, for papers by Sabine Stegmaier Breakdown of academic impact, for papers by Katsuaki Kanbe Breakdown of academic impact, for papers by Manabu Inobe Breakdown of academic impact, for papers by Paolo Durigutto Breakdown of academic impact, for papers by Jean‐Claude Bensa Breakdown of academic impact, for papers by Tamara H. Ramwadhdoebé Breakdown of academic impact, for papers by Yuki Nanke
Rankless by CCL
2026